Zhiyi Li, MBA, MA

Director
Kyowa Kirin Inc
Princeton, New Jersey, United States

Disclosure information not submitted.

Presentation(s):

• SAT-742 - Real-world biochemical effectiveness in patients with XLH treated with burosumab or phosphate and vitamin D

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT

• ORF08-05 - Real-World Effectiveness of Burosumab in Adults with X-Linked Hypophosphatemia (XLH): An Item-Level Analysis of the Western Ontario and McMaster Universities Osteoarthritis Index

  Saturday, June 13, 2026
  10:15 AM - 10:30 AM CT